New algorithm uses artificial intelligence to help manage type 1 diabetes. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2020 / 06 / 200612172204.htm ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

The study included 12 patients who suffer from a subset of Type 1 diabetes known as hypoglycemic unawareness, characterized ...

Type 1 diabetes is more prevalent in Finland than anywhere else in the world, affecting approximately 50,000 people. New ...

Nanotherapy offers new hope for the treatment of Type 1 diabetes. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2022 / 01 / 220117115111.htm. Northwestern University.

This week, the FDA approved a new treatment called teplizumab that delays the onset of type 1 diabetes. TZIELD, the brand name, will total $193,000 over the 14-day treatment.

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...

He and his colleagues were the first to study how liraglutide, another drug for Type 2 diabetes, might work in patients with Type 1 diabetes in a study he published in 2011. “As we extended this work, ...

The trouble is that in type 1 diabetes, when the symptoms first present, it’s too late.” The treatment comes in a single 14-day course of infusions that each last 30 to 60 minutes.

LINCOLN, Neb. (KOLN) - Popular GLP-1 drugs have been gaining traction across the United States as a means for weight loss. The drug has been approved to help treat type-2 diabetes, but a new study ...

Researchers and physicians at Oregon Health & Science University, using artificial intelligence and automated monitoring, have designed a method to help people with type 1 diabetes better manage ...